Remimazolam sedation for high-risk ERCP
Treatments studied
Part of Digestive system clinical trials.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 90 years old.
- Your body mass index (BMI) is between 18 and 30.
- You have an ASA physical status of 3 or 4 (severe systemic disease).
- You do not have uncontrolled heart or lung problems, serious bleeding issues, end-stage liver or kidney failure, or other conditions the doctor feels would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This trial tests a sedative called remimazolam for women undergoing gynecological surgeries like hysterectomy or fibroid removal. The goal is to see how it works and if it's a good option for anesthesia.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
Hear when a new the Severity and Duration of Intraoperative Hypotension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.